This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can Phosphate Binders Drive DaVita Stock Before Q2 Earnings?
by Zacks Equity Research
DVA rides early momentum from phosphate binders ahead of second-quarter 2025 earnings, but PD supply issues may cloud growth.
Option Care (OPCH) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of +2.50% and +4.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
DaVita HealthCare (DVA) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
DaVita HealthCare (DVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health Q2 Earnings Miss on Declining Patient Days
by Zacks Equity Research
CYH posts Q2 loss despite revenue beat, as patient days and adjusted admissions decline year over year.
Molina Healthcare Q2 Earnings Miss on Rising Medical Care Costs
by Zacks Equity Research
MOH's Q2 earnings lag estimates as rising medical care costs offset gains from premiums and rate hikes.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Encompass Health (EHC) Loses 10.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Encompass Health (EHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Are Medical Stocks Lagging Encompass Health (EHC) This Year?
by Zacks Equity Research
Here is how Encompass Health (EHC) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Here's Why Encompass Health (EHC) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for OUSM
Encompass Health Opens Rehabilitation Hospital in Florida
by Zacks Equity Research
EHC opens its 23rd Florida rehab hospital in Daytona Beach, boosting access to care and supporting its 2025 growth plan.
Zacks Industry Outlook Highlights Quest Diagnostics, Encompass Health, DaVita and The Pennant
by Zacks Equity Research
DGX, EHC, DVA, and PNTG are riding the outpatient healthcare shift as tech, AI, and aging demand reshape the care landscape.
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
by Debanjana Dey
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
Select Medical Expands Presence in Tennessee With Ballad Health Deal
by Zacks Equity Research
SEM partners with Ballad Health to relocate and expand its Tri-Cities critical illness recovery hospital, boosting care access in Tennessee by being able to treat more patients grappling with serious illnesses.
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Encompass Health (EHC) and EUROFINS SCIENT (ERFSF) have performed compared to their sector so far this year.
Here's Why Encompass Health (EHC) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why MOH Shares Are Attracting Prudent Investors Now
by Zacks Equity Research
Molina Healthcare draws investor interest with strong earnings growth, contract wins and premium revenue momentum despite rising costs.
Why Encompass Health (EHC) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas
by Zacks Equity Research
EHC unveils plans for a 50-bed rehabilitation hospital in North Las Vegas, bringing improved health outcomes to the region's residents and further solidifying its Nevada footprint.
Here's Why ENSG Shares Are Attracting Prudent Investors Now
by Zacks Equity Research
The Ensign Group's 23.8% stock gain, strong earnings outlook and low debt levels are drawing investor attention despite rising costs.
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Encompass Health (EHC) and Elanco Animal Health Incorporated (ELAN) have performed compared to their sector so far this year.
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Best Growth Stocks to Buy for June 6th
by Zacks Equity Research
LTM, EHC and EWCZ made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 6, 2025.